Amendment No. 1 to Research, License and Option Agreement (“Amendment No. 1”)Wave Life Sciences Ltd. • March 12th, 2018 • Pharmaceutical preparations
WHEREAS, the parties hereto desire to amend certain terms of the Agreement in order to provide for an extension of the period of time to nominate the Additional Programs,
